Company
Headquarters: Jerusalem, Israel
CEO: Mr. Yosef Yeshayahu Wasserman
₪14.5 Million
ILS as of Jan. 1, 2024
US$4.0 Million
| Company | Market Cap (USD) |
|---|---|
| Abbott | $192.67 B |
| Stryker Corporation | $113.24 B |
| Medtronic | $111.60 B |
| Boston Scientific Corporation | $85.22 B |
| Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $49.33 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Erech Finance Cahalacha Ltd, together with its subsidiaries, provides loans and credit services to small and medium sized enterprises, associations, and individual borrowers in Israel. The company operates through Non-Banking Credit and Biomed segments. It is also involved in the development of drugs in the areas of youth diabetes and cancer. The company is based in Jerusalem, Israel.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Erech Finance Cahalacha Ltd has the following listings and related stock indices.
Stock: TASE: EFNC wb_incandescent
Headquarters:
Ya'akov Eliav 5
Jerusalem, 9123101
Israel
Phone: 972 3 930 1094
Fax: 972 3 934 1094